Skip to content
Axe Capital logo Axe Capital Trading News

Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

Coverage focus:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest Finance Headlines

A Credo Insider Sold $11.3 Million in Stock After a 121% Run — Here's What Investors Should Know
2026-07-16 22:31 The Motley Fool Positive Axe Cap view: Selective

Credo Technology Group's COO Yat Tung Lam sold 50,000 shares worth $11.3 million on July 15, 2026, through a pre-planned Rule 10b5-1 trading arrangement. Despite the sale, Lam maintains over 3 million shares in the company. The article characterizes this as routine profit-taking after the stock's 121% one-year run, not a sign of concern. Credo reported strong fiscal results with revenue exceeding $1.3 billion and net income of $472.3 million, though the company faces concentration risk with 90% of revenue from its top 10 customers.

Axe note: Credo’s COO sold $11.3 million in shares after a stellar 121% rally, illustrating routine profit-taking amid strong growth but notable customer concentration risk.

Why AtaiBeckley Stock Soared Today
2026-07-16 22:12 The Motley Fool Positive Axe Cap view: Selective

AtaiBeckley shares surged 33.40% after pharmaceutical giant Eli Lilly agreed to acquire the mental health-focused biotechnology company for $6.75 per share in cash, plus up to $2.50 per share in milestone payments. The total deal valuation could reach approximately $3.8 billion if all conditions are met. The acquisition is expected to close in Q3, subject to shareholder and regulatory approval.

Axe note: Eli Lilly’s acquisition of AtaiBeckley highlights growing global interest in innovative mental health therapies with some ripple effects for local biotech sentiment.

Is IBM's Crash Really a Buying Opportunity?
2026-07-16 22:11 The Motley Fool Neutral Axe Cap view: Selective

IBM stock plummeted over 25% following an earnings warning, erasing $67 billion in market value. The decline was triggered by customers shifting spending away from IBM's software toward AI servers and memory chips. While the short-term outlook is concerning, the analyst views this as a cyclical timing issue rather than a fundamental problem, suggesting the crash may present a buying opportunity for patient investors.

Axe note: IBM’s sharp plunge faced a cyclical shift in tech spending—worth watching, but not without risks.

Focus Areas

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

Market notes